Latest Insider Transactions at Optimize Rx Corp (OPRX)
This section provides a real-time view of insider transactions for Optimize Rx Corp (OPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OptimizeRx Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OptimizeRx Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+13.85%
|
$29,000
$2.46 P/Share
|
|
May 18
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,500
-16.07%
|
$652,500
$45.85 P/Share
|
|
May 17
2021
|
Stephen L Silvestro Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,242
+50.0%
|
$92,694
$7.51 P/Share
|
|
May 17
2021
|
Stephen L Silvestro Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,242
-100.0%
|
$556,164
$42.72 P/Share
|
|
May 17
2021
|
Miriam J Paramore PRESIDENT AND CSO |
SELL
Open market or private sale
|
Direct |
15,000
-62.29%
|
$630,000
$42.95 P/Share
|
|
Mar 31
2021
|
Gus D Halas Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+0.83%
|
-
|
|
Mar 31
2021
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+1.64%
|
-
|
|
Mar 31
2021
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+2.4%
|
-
|
|
Mar 31
2021
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+1.63%
|
-
|
|
Mar 31
2021
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+2.98%
|
-
|
|
Mar 25
2021
|
William J Febbo CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,710
-4.54%
|
$1,255,370
$47.44 P/Share
|
|
Mar 25
2021
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
394,739
+40.17%
|
$1,184,217
$3.21 P/Share
|
|
Mar 25
2021
|
William J Febbo CEO |
SELL
Open market or private sale
|
Direct |
80,000
-29.27%
|
$3,680,000
$46.1 P/Share
|
|
Mar 24
2021
|
William J Febbo CEO |
SELL
Open market or private sale
|
Direct |
20,000
-6.82%
|
$1,000,000
$50.5 P/Share
|
|
Jan 29
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,315
+4.56%
|
$30,205
$7.51 P/Share
|
|
Jan 29
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,032
-5.53%
|
$236,504
$47.25 P/Share
|
|
Jan 13
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.21%
|
$35,000
$7.51 P/Share
|
|
Jan 13
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-5.5%
|
$190,000
$38.89 P/Share
|
|
Jan 04
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,566
+4.6%
|
$34,264
$4.99 P/Share
|
|
Jan 04
2021
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,334
-9.19%
|
$266,688
$32.88 P/Share
|
|
Dec 31
2020
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+2.47%
|
-
|
|
Dec 31
2020
|
Gus D Halas Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+1.24%
|
-
|
|
Dec 31
2020
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+3.61%
|
-
|
|
Dec 31
2020
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+2.45%
|
-
|
|
Dec 31
2020
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+4.51%
|
-
|
|
Dec 31
2020
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,186
+6.74%
|
-
|
|
Nov 12
2020
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+14.19%
|
$30,000
$2.46 P/Share
|
|
Nov 11
2020
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-16.54%
|
$360,000
$24.05 P/Share
|
|
Sep 30
2020
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+3.69%
|
-
|
|
Sep 30
2020
|
Gus D Halas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+1.84%
|
-
|
|
Sep 30
2020
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+5.43%
|
-
|
|
Sep 30
2020
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+3.66%
|
-
|
|
Sep 30
2020
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+6.81%
|
-
|
|
Sep 30
2020
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,186
+7.22%
|
-
|
|
Mar 31
2020
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,187
+7.79%
|
-
|
|
May 14
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,874
-1.14%
|
$557,362
$13.61 P/Share
|
|
May 13
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,126
-0.56%
|
$92,638
$13.72 P/Share
|
|
May 10
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-1.93%
|
$325,000
$13.76 P/Share
|
|
May 09
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,000
-3.71%
|
$650,000
$13.57 P/Share
|
|
Mar 18
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,760
-0.57%
|
$116,400
$15.15 P/Share
|
|
Mar 15
2019
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,637
-1.0%
|
$204,555
$15.0 P/Share
|